Helse Moere Og Romsdal HF

At Helse Moere Og Romsdal HF, clinical trials in cardiovascular disease and neurology focus on major conditions such as atherosclerotic cardiovascular disease, acute myocardial infarction, atrial fibrillation, stroke, and transthyretin amyloid cardiomyopathy. The studies are designed to test new ways to prevent serious events, improve recovery after vascular injury, and evaluate better treatment options for people at high risk.

• Stroke prevention after ischemic events and transient ischemic attacks
• Heart rhythm-related clot prevention in atrial fibrillation
• New therapies for myocardial infarction and cardiomyopathy

These trials aim to strengthen prevention and long-term care for patients with high-risk cardiovascular and cerebrovascular conditions.

The site has a strong oncology portfolio covering breast cancer, lung cancer, melanoma, prostate cancer, testicular cancer, multiple myeloma, and acute myeloid leukemia. Research here explores both standard cancer care and newer approaches such as immunotherapy, targeted treatment selection, and precision medicine for hard-to-treat disease.

• Immunotherapy for lung cancer and melanoma
• Targeted cancer treatments matched to tumor biology
• Precision medicine for rare and advanced cancers

These studies aim to improve survival, reduce relapse, and identify treatments that are better matched to each patient’s cancer profile.

Clinical trials in immune system and digestive disease research include Crohn’s disease, celiac disease, eosinophilic esophagitis, and short bowel syndrome. The work focuses on easing symptoms, maintaining disease control, and testing therapies that may offer better long-term management for chronic inflammatory conditions.

• Biologic and targeted therapies for Crohn’s disease
• Symptom relief and healing in celiac disease and eosinophilic esophagitis
• Supportive treatment for short bowel syndrome

These trials are aimed at improving daily functioning and reducing disease flares in people living with chronic gastrointestinal and immune-mediated disorders.

Research in neurology and related specialties includes studies of multiple sclerosis, chronic migraine, cluster headache, and sudden hearing loss. The clinical trials are evaluating whether new or repurposed treatments can improve symptom control, reduce attacks, and support recovery in conditions that can strongly affect quality of life.

• Disease-modifying therapy for multiple sclerosis
• Headache prevention in chronic and episodic cluster headache and migraine
• Hearing recovery approaches for sudden sensorineural hearing loss

At the Aalesund clinic, this area of research is centered on better symptom management and more effective long-term care for neurological and otologic disorders.

Trials in respiratory disease, infectious disease, and ear-nose-throat care involve COPD, lower respiratory tract infection, pneumonia in children, COVID-19, and chronic wet cough. The studies are assessing new ways to reduce exacerbations, improve infection outcomes, and support recovery after acute illness.

• Exacerbation prevention in COPD
• Antibiotic effectiveness in childhood respiratory infections
• Antiviral treatment for acute COVID-19 and long-term complications

This research reflects a practical focus on improving treatment effectiveness and recovery across common respiratory and infectious conditions.

Trials in rheumatology, dermatology, and musculoskeletal disease address rheumatoid arthritis and psoriasis, with some studies also looking at surgical wound care and inflammation-related outcomes. The research is aimed at finding better strategies to control chronic inflammation, maintain disease remission, and improve treatment convenience.

• Therapy optimization in rheumatoid arthritis
• New treatment options for psoriasis
• Bleeding and wound-healing support in surgical care

These studies combine immune-mediated disease management with efforts to improve everyday treatment experience and clinical outcomes.

The research portfolio also includes digestive, hormonal, and rare disease trials such as primary adrenal insufficiency, short bowel syndrome, and other complex chronic conditions. These studies are designed to improve symptom control, support long-term disease management, and assess whether newer therapies can offer more reliable benefit.

• Hormone replacement and quality of life in adrenal insufficiency
• Long-term support for rare gastrointestinal disorders
• Improved symptom management in chronic complex disease

At Helse Møre og Romsdal HF, this area highlights care for patients with less common but clinically important chronic diseases.